Joseph Beaulieu
Nessuna posizione attualmente
Storia della carriera di Joseph Beaulieu
Precedenti posizioni note di Joseph Beaulieu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EPIZYME, INC. | Comptroller/Controller/Auditor | 01/07/2018 | 01/02/2023 |
| Treasurer | 01/07/2018 | - | |
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Analyst-Equity | 01/05/2009 | 31/08/2011 |
| Direttore della Ricerca - Azioni | 01/05/2009 | 31/08/2011 | |
| ABN AMRO Securities (USA), Inc. | Analyst-Equity | 31/10/1999 | 31/10/1999 |
Formazione di Joseph Beaulieu
| The University of Chicago | Undergraduate Degree |
| University of Illinois | Graduate Degree |
| Wallace E Carroll School of Management | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Analyst-Equity | 2 |
| Undergraduate Degree | 2 |
| Director of Research - Equity | 1 |
Settori
| Consumer Services | 4 |
| Finance | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
| ABN AMRO Securities (USA), Inc. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Joseph Beaulieu
- Esperienza
